Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage

Gerner S, Kuramatsu J, Sembill J, Sprügel M, Hagen M, Knappe RU, Endres M, Haeusler KG, Sobesky J, Schurig J, Zweynert S, Bauer M, Vajkoczy P, Ringleb PA, Purrucker JC, Rizos T, Volkmann J, Muellges W, Kraft P, Schubert AL, Erbguth F, Nueckel M, Schellinger PD, Glahn J, Knappe UJ, Fink GR, Dohmen C, Stetefeld H, Fisse AL, Minnerup J, Hagemann G, Rakers F, Reichmann H, Schneider H, Rahmig J, Ludolph AC, Stoesser S, Neugebauer H, Roether J, Michels P, Schwarz M, Reimann G, Baezner H, Schwert H, Classen J, Michalski D, Grau A, Palm F, Urbanek C, Woehrle JC, Alshammari F, Horn M, Bahner D, Witte OW, Guenther A, Hamann GF, Engelhorn T, Lücking H, Dörfler A, Schwab S, Huttner H (2019)


Publication Type: Journal article

Publication year: 2019

Journal

Book Volume: 50

Pages Range: 1392-1402

Journal Issue: 6

DOI: 10.1161/STROKEAHA.118.023492

Abstract

Background and Purpose Given inconclusive studies, it is debated whether clinical and imaging characteristics, as well as functional outcome, differ among patients with intracerebral hemorrhage (ICH) related to vitamin K antagonists (VKA) versus non-vitamin K antagonist (NOAC)-related ICH. Notably, clinical characteristics according to different NOAC agents and dosages are not established.

Authors with CRIS profile

Involved external institutions

How to cite

APA:

Gerner, S., Kuramatsu, J., Sembill, J., Sprügel, M., Hagen, M., Knappe, R.U.,... Huttner, H. (2019). Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage. Stroke, 50(6), 1392-1402. https://dx.doi.org/10.1161/STROKEAHA.118.023492

MLA:

Gerner, Stefan, et al. "Characteristics in Non-Vitamin K Antagonist Oral Anticoagulant-Related Intracerebral Hemorrhage." Stroke 50.6 (2019): 1392-1402.

BibTeX: Download